Moreover, the expression of lipogenesis-related hepatic genes, such as SREBP-1c, SCD, FAS, ACLY, ACC, and LXRα were assessed using RT-PCR in differentiated HepaRG cells treated with IBD medications for 48 h. This evidence concerns the gene FAS and inflammatory bowel disease.